Search Within

Medical Physics

Formats
  1. Journal Article (2641)
  2. Meeting Abstract (1820)
  3. Conference Paper (205)
  4. Book Section (164)
  5. Review (122)
  6. Editorial (52)
  7. Guidelines (22)
  8. Correspondence (18)
  9. Miscellaneous (11)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Radiotherapy Physics Service (2116)
  2. Radiology, Department of (1231)
  3. Sloan Kettering Institute Postdocs (1187)
  4. GSK Faculty (1077)
  5. Radiation Oncology, Department of (938)
  6. Department of Medicine (741)

More Groups

People
  1. Joseph Deasy (533)
  2. Ellen Yorke (452)
  3. John Humm (439)
  4. Pat Zanzonico (361)
  5. Steven Larson (335)
  6. C Ling (331)

More People

Years
  1. 2025 (168)
  2. 2024 (294)
  3. 2023 (258)
  4. 2022 (306)
  5. 2021 (294)
  6. 2020 (220)

More Years

Publications
  1. Medical Physics (1057)
  2. International Journal of Radiation Oncology, Biology, Physics (807)
  3. Journal of Nuclear Medicine (305)
  4. Radiotherapy and Oncology (175)
  5. Journal of Applied Clinical Medical Physics (117)
  6. Physics in Medicine and Biology (94)

More Publications

Publishers
  1. Elsevier Inc. (1208)
  2. American Association of Physicists in Medicine (1057)
  3. Society of Nuclear Medicine (305)
  4. Springer (244)
  5. Elsevier Science, Inc. (185)
  6. American Association for Cancer Research (157)

More Publishers

Results (5071)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Radiobiology and radiation dosimetry in nuclear medicine: Therapy, diagnosis, and considerations for sensitive populations
    Book Section

    Salvatori, M.; Cremonesi, M.; Indovina, L.; Chianelli, M.; McEwan, A. J. B.; Zanzonico, P.
    In Strauss, H. W.; Mariani, G.; Volterrani, D.; Larson, S. M. (Eds.) Nuclear Oncology: Pathophysiology and Clinical Applications. 1st ed (2013)

    Fulltext@MSK | Save
  • Predictors of gastrointestinal toxicity during pelvic radiotherapy
    Meeting Abstract

    Yang, T. J.; Oh, J. H.; Son, C.; Apte, A.; Deasy, J. O.; Wu, A. J. C.; Goodman, K. A.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR(+)) modified T cells targeting prostate-specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Slovin, S. F.; Wang, X.; Hullings, M.; Arauz, G.; Bartido, S.; Lewis, J. S.; Schoder, H.; Zanzonico, P.; Scher, H. I.; Sadelain, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase I trial of zirconium 89 (Zr89) radiolabeled J591 in metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Morris, M. J.; Pandit-Taskar, N.; Carrasquillo, J. A.; O'Donoghue, J. A.; Humm, J.; Lyashchenko, S. K.; Haupt, E. C.; Bander, N. H.; Tagawa, S. T.; Holland, J. P.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR(+)) modified T cells targeting prostate specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Slovin, S. F.; Wang, X.; Hullings, M.; Arauz, G.; Bartido, S.; Lewis, J. S.; Schoder, H.; Zanzonico, P.; Scher, H. I.; Riviere, I.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Intraperitoneal radioimmunotherapy (RIT) for desmoplastic small round cell tumor (DSRCT): Initial results from a phase I trial
    Meeting Abstract

    Modak, S.; La Quaglia, M. P.; Carrasquillo, J. A.; Zanzonico, P.; Enero, C.; Pandit-Taskar, N.; Kang, H. J.; Cheung, N. K. V.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Hepatic arterial infusion for unresectable intrahepatic cholangiocarcinoma: An update on survival from two prospective clinical trials
    Meeting Abstract

    Konstantinidis, I.; Do, R. K. G.; Gultekin, D. H.; Gonen, M.; Schwartz, L. H.; Fong, Y.; Allen, P. J.; D'Angelica, M. I.; DeMatteo, R. P.; Klimstra, D. S.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Post-treatment alterations in 18F-dihydrotestosterone (FDHT) and FDG PET/CT in metastatic castration-resistant prostate cancer (mCRPC) treated with cabozantinib
    Meeting Abstract

    Fox, J. J.; Haupt, E. C.; Humm, J.; Autio, K. A.; Rathkopf, D. E.; Vargas, H. A.; Schöder, H.; Hricak, H.; Larson, S. M.; Scher, H. I.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Evaluating 18F-16B-fluoro-5α-dihydrotestosterone (FDHT) and FDG-PET as a measure of disease progression in metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Autio, K. A.; Fox, J. J.; Schneider, C. W.; Schöder, H.; Humm, J.; Rathkopf, D. E.; Slovin, S. F.; Danila, D. C.; Haupt, E. C.; Larson, S. M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Diffusion tensor tractography of the arcuate fasciculus in patients with brain tumors: Comparison between deterministic and probabilistic models
    Journal Article

    Li, Z.; Peck, K. K.; Brennan, N. P.; Jenabi, M.; Hsu, M.; Zhang, Z.; Holodny, A. I.; Young, R. J.
    Journal of Biomedical Science and Engineering (2013)

    Fulltext@MSK | Save